Organon Q1 2024 Adj EPS $1.22 Beats $0.93 Estimate, Sales $1.622B Beat $1.563B Estimate
Organon Q1 2024 Adj EPS $1.22 Beats $0.93 Estimate, Sales $1.622B Beat $1.563B Estimate
Organon 2024年第一季度調整後每股收益1.22美元超過0.93美元的預期，16.22億美元的銷售額超過15.63億美元的預期
Organon (NYSE:OGN) reported quarterly earnings of $1.22 per share which beat the analyst consensus estimate of $0.93 by 31.18 percent. This is a 12.96 percent increase over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $1.622 billion which beat the analyst consensus estimate of $1.563 billion by 3.76 percent. This is a 5.46 percent increase over sales of $1.538 billion the same period last year.
Organon（紐約證券交易所代碼：OGN）公佈的季度收益爲每股1.22美元，比分析師普遍預期的0.93美元高出31.18％。這比去年同期的每股收益1.08美元增長了12.96％。該公司公佈的季度銷售額爲16.22億美元，比分析師普遍預期的15.63億美元高出3.76％。這比去年同期的15.38億美元銷售額增長了5.46％。